Why the study?
Using drugs to activate potassium channels has the potential to treat conditions like epilepsy, heart arrhythmias, and pain.
Population
Potassium channels
Comparison
Negatively charged activators (NCAs)
Design
X-ray crystallography, functional analysis, and molecular dynamics simulations
Authors
Loading...
May guide activator design for epilepsy, arrhythmias, and pain; hypothesis-generating with translation to humans untested.
Identifies a common mechanism for activating potassium channels via negatively charged activators, offering a potential target for rational drug design for conditions like epilepsy, arrhythmias, and pain.
Schewe et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: